KEYTRUDA 25 mg/mL concentrate for solution for infusion, IO102-IO103
IOB-013/KN-D18
Phase 3 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, IO102-IO103 for Previously untreated, unresectable, or metastatic melanoma is a Phase 3 program (small_molecule) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Previously untreated, unresectable, or metastatic melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active